Patent application number | Description | Published |
20080220530 | Biomarkers - The invention relates to methods for diagnosing or monitoring psychotic disorders such as schizophrenic or bipolar disorders, comprising measuring the level of one or more biomarker(s) present in a cerebrospinal fluid sample taken from a test subject, said biomarker(s) being selected from the group consisting of: glucose, lactate, acetate species and pH. The invention also relates to methods of diagnosing or monitoring a psychotic disorder in a subject comprising providing a test sample of CSF from the subject, performing spectral analysis on said CSF test sample to provide one or more spectra, and, comparing the one or more spectra with one or more control spectra. The invention also relates to sensors, biosensors, multi-analyte panels, arrays, assays and kits for performing methods of the invention. | 09-11-2008 |
20090093430 | Biomarkers and methods for identification of agents useful in the treatment of affective disorders - Potential therapeutic, agent for the prevention, treatment or amelioration of an affective disorder, such as a bipolar disorder, depression or anxiety disorder are identified. Also provided are methods for diagnosing and monitoring affective disorders. The methods are based on changes in expression of one or more genes that are differentially expressed in affective disorders. | 04-09-2009 |
20090176257 | Methods and Biomarkers for Diagnosing and Monitoring Psychotic Disorders - The invention relates to methods of diagnosing or monitoring a psychotic disorder in a subject comprising providing a test biological sample from the subject, performing spectral analysis on said test biological sample to provide one or more spectra, and, comparing the one or more spectra with one or more control spectra. The invention also relates to methods for diagnosing or monitoring psychotic disorders such as schizophrenic or bipolar disorders, comprising measuring the level of one or more biomarkers present in a biological sample taken from a test subject, said biomarkers being selected from the group consisting of transthyretin, ApoA1: VLDL, LDL and aromatic species such as plasma proteins. The invention also relates to sensors, biosensors, multi-analyte panels, arrays, assays and kits for performing methods of the invention. | 07-09-2009 |
20090286238 | Methods to Monitor, Diagnose and Identify Biomarkers for Psychotic Disorders - A stimulated or non-stimulated T-cell sample can be used to diagnose or monitor a psychotic disorder, to identify a biomarker, or as to test a considerate as a potential therapeutic agent. | 11-19-2009 |
20100129919 | METHODS AND BIOMARKERS FOR DIAGNOSING AND MONITORING PSYCHOTIC DISORDERS - A method of diagnosing or monitoring a psychotic disorder, or predisposition thereto, comprises measuring, in a sample taken from a subject, the level of a biomarker selected from clusterin precursor, inter α-trypsin inhibitor, IgM, apolipoprotein A2 and α2 H5 glycoprotein. | 05-27-2010 |
20100291597 | SECRETOGRANIN AND VGF PEPTIDE BIOMARKERS AND USES THEREOF - Secretogranin II and VGF peptides are biomarkers for major depressive disorder. They are useful in methods of diagnosing, monitoring and screening. | 11-18-2010 |
20110165554 | METHODS AND BIOMARKERS FOR DIAGNOSING AND MONITORING PSYCHOTIC DISORDERS - A method of diagnosing or monitoring a psychotic disorder, or predisposition thereto, comprises measuring, in a sample taken from a subject, the levels of one or more peptide biomarkers listed herein. | 07-07-2011 |
20120040852 | BIOMARKERS - The present invention relates to a method of diagnosing or monitoring schizophrenia or other psychotic disorders | 02-16-2012 |
20120251553 | BIOMARKERS FOR SCHIZOPHRENIA OR OTHER PSYCHOTIC DISORDERS - The invention relates to a method of diagnosing or monitoring schizophrenia or other psychotic disorder. | 10-04-2012 |
20130012402 | BIOMARKERS - The invention relates to a method of diagnosing or monitoring schizophrenia or other psychotic disorder. | 01-10-2013 |
20130017970 | BIOMARKERSAANM Bahn; SabineAACI CambridgeAACO GBAAGP Bahn; Sabine Cambridge GBAANM Levin; YishaiAACI CambridgeAACO GBAAGP Levin; Yishai Cambridge GBAANM Schwarz; EmanuelAACI CambridgeAACO GBAAGP Schwarz; Emanuel Cambridge GB - The invention relates to a method of diagnosing or monitoring schizophrenia or other psychotic disorder. | 01-17-2013 |
20130059750 | BIOMARKERS - The invention relates to a method of diagnosing or monitoring schizophrenia or other psychotic disorder. | 03-07-2013 |
20130078645 | BIOMARKERS - The invention relates to a method of diagnosing or monitoring schizophrenia or other psychotic disorder. The biomarkers used are selected from cyclophilin A, cytosalic non-specific dipepditase, Caoctosin-like protein, Glucose-6-phosphate isomerase, uncharacterized protein KIAA0423, myosin 14, myosin 15, nicotinamide phosphoribosyltransferase, pyruvate kinase isozyme R/L, phosphoglyterate mutase 4. | 03-28-2013 |
20130171166 | BIOMARKERS - The invention relates to a method of diagnosing or monitoring major depressive disorder using MMP-3 as a biomarker. | 07-04-2013 |
20130178385 | BIOMARKERS - The invention relates to a method of diagnosing or monitoring schizophrenia or other psychotic disorder. | 07-11-2013 |
20130224221 | BIOMARKERS FOR SCHIZOPHRENIA - The invention relates to a method of diagnosing or monitoring schizophrenia or other psychotic disorder. | 08-29-2013 |
20140200150 | BIOMARKERS - The invention relates to a method of differentially diagnosing schizophrenia, bipolar disorder and major depressive disorder. | 07-17-2014 |
20140200151 | BIOMARKERS - The invention relates to a method of differential diagnosis of schizophrenia or other psychotic disorder from a further psychiatric disorder. | 07-17-2014 |